Morgan Stanley’s Iveda Solutions IVDA Stock Holding History

Morgan Stanley’s Portfolio IVDA Stock Details IVDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,200	Closed	-$1.01K	–	8399
2025 Q4	$1.01K	Buy	+1,200	New	+$1.34K	﹤0.01%	7365

Other funds holding IVDA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Morgan Stanley's IVDA Position: Q1 2026 in Review

Morgan Stanley sold out of Iveda Solutions (IVDA) in Q1 2026, closing a stake of 1,200 shares — an estimated $1.01K sold.

Morgan Stanley first reported a position in IVDA in Q4 2025 and held it in 1 quarter. The position peaked at $1.01K in Q4 2025. 13 funds tracked by Wall St. Rank hold IVDA as of Q1 2026.

Morgan Stanley reported no remaining Iveda Solutions position as of Q1 2026 after selling out during the quarter.
Morgan Stanley sold 1,200 Iveda Solutions shares in Q1 2026, an estimated $1.01K.
Morgan Stanley first reported a position in Iveda Solutions in Q4 2025 and held it in 1 quarter.
Morgan Stanley's Iveda Solutions position peaked at $1.01K in Q4 2025.
13 funds tracked by Wall St. Rank held Iveda Solutions as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.